TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · major macro event coming up
XFOR

X4 Pharmaceuticals Inc

Healthcare · Biotechnology

2.90$ -3.8% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

X4 Pharmaceuticals Inc (XFOR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 253 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet XFOR
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
173 147 112 211 178 146 130 105 164 290 270 253
148 122 87 175 143 112 96 73 133 262 242 219
132 99 60 147 97 56 40 39 70 217 217 195
142 114 81 169 135 102 87 63 122 253 234 208
0.4 0.6 0.7 0.9 1.1 1.7 1.2 1.9 1.6 0.6 1.1 2.0
– 0.0 – 0.8 2.4 2.8 3.1 3.2 4.1 4.5 4.6 5.5
17 17 17 17 17 17 17 17 17 17 17 17
– – – 10 10 10 9.8 9.6 9.4 9.3 9.1 13
106 96 111 116 119 124 107 101 102 104 102 98
25 23 24 29 29 33 26 23 24 26 24 19
1.1 1.1 1.1 1.2 1.2 1.3 1.3 1.4 1.2 1.0 0.7 0.5
8.1 8.9 8.9 8.0 8.6 8.6 11 7.7 5.1 5.7 5.1 3.9
54 55 55 75 75 75 76 76 76 76 77 77
68 51 1.0 94 60 22 23 4.0 62 186 168 155
-459 -478 -530 -439 -476 -515 -515 -541 -571 -595 -615 -631
6.6 6.6 6.7 6.7 6.7 6.8 6.9 7.4 43 111 126 126

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?